NetworkNewsBreaks

FridayApr 17, 2026 12:31 pm

NetworkNewsBreaks – Why Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Is ‘One to Watch’

Artificial intelligence-powered cardiovascular medicine company Cardio Diagnostics Holdings (NASDAQ: CDIO) was featured in a recent article that discussed its focus on cardiovascular disease prevention, detection, and management. The publication reads, “The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators… At the core of its strategy is the integration of epigenetics, genetics, and artificial intelligence to generate insights from a patient’s molecular profile. By analyzing both inherited predisposition and changes influenced by lifestyle and environment, the company’s platform is designed to provide a more complete view of cardiovascular disease.”…

Continue Reading

FridayApr 17, 2026 9:10 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Closes $10 Million Public Offering to Advance Cardiac Technology Commercialization

HeartBeam (NASDAQ: BEAT) announced the closing of its underwritten public offering of 12.5 million shares of common stock, generating gross proceeds of $10 million before expenses, with the transaction completed on April 16, 2026. The offering, supported by key stakeholders including ClearCardio(TM), company leadership and institutional investors, will fund commercialization of HeartBeam’s FDA-cleared 12-lead synthesized ECG system, further development of its extended-wear patch and heart attack detection technologies, expansion of AI capabilities and general corporate purposes To view the full press release, visit https://nnw.fm/9iNYY About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the…

Continue Reading

ThursdayApr 16, 2026 12:05 pm

NetworkNewsBreaks – Roth Capital Partners Appoints Seth Appel Head of ATM and Equity Alternatives Banking

Roth Capital Partners announced the appointment of Seth Appel as head of ATM and equity alternatives banking, bringing more than 30 years of capital markets experience to expand the firm’s equity capital markets capabilities and support growth companies in raising capital. In connection with the appointment, Appel will also serve as co-chief investment officer of the RoHo Capital Opportunities Fund, a joint venture with Horizon Technology Finance Corporation (NASDAQ: HRZN), focused on providing debt financing solutions to small- and micro-cap public companies. To view the full press release, visit https://nnw.fm/Mxqo7 About ROTH ROTH is a relationship-driven investment bank focused on…

Continue Reading

ThursdayApr 16, 2026 10:30 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Launches Quantum-Ready HPC GPU Network in New York and Philadelphia 

Datavault AI (NASDAQ: DVLT) a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, announced that the first sites of its quantum-ready high-performance computing GPU network are now live in New York and Philadelphia, with full commercial availability of its planned 48,000-GPU fleet expected in Q3 2026. The network, designed to operate outside the hyperscaler supply chain, will scale across 1,000 micro-edge sites in more than 100 U.S. cities and support low-latency AI inference, data tokenization and monetization through the company’s IDE(R), DataValue(R) and DataScore(R) platforms, positioning it as an alternative source of secure enterprise AI compute capacity amid ongoing GPU supply constraints. To view…

Continue Reading

ThursdayApr 16, 2026 9:48 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Reports FY 2025 Net Income of $249 Million 

Oncotelic Therapeutics (OTCQB: OTLC), a clinical-stage biopharmaceutical company focused on orphan oncology and advanced drug platforms, reported financial results for the fiscal year ended Dec. 31, 2025, with net income of approximately $249.0 million compared to a net loss of $4.8 million in FY 2024, primarily driven by a non-cash gain of approximately $365.4 million from the increased valuation of its GMP Biotechnology joint venture, partially offset by a deferred tax provision of $111.6 million. To view the full press release, visit https://nnw.fm/bx199 About Oncotelic Oncotelic (f/k/a Mateon Therapeutics, Inc.), was formed in the State of New York in 1988 as OXiGENE, Inc., was reincorporated in the State…

Continue Reading

ThursdayApr 16, 2026 9:30 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Advances Commercialization With Robotics Supply Agreement

Nightfood Holdings (OTCQB: NGTF), operating through its TechForce Robotics subsidiary, announced the execution of a strategic supply agreement with NUWA Robotics Corp. and Foxconn, marking its transition from development and pilot programs to commercial deployment of robotic platforms. The agreement establishes a framework for engineering, manufacturing and commercialization, with TechForce retaining exclusive intellectual property ownership while leveraging NUWA’s system integration expertise and Foxconn’s global manufacturing capabilities to scale production and support growing demand for its Robotics-as-a-Service model. To view the full press release, visit https://nnw.fm/Zy1Kg About TechForce Robotics TechForce Robotics, Inc., a whollyowned subsidiary of the Company, is an AI-Enhanced…

Continue Reading

ThursdayApr 16, 2026 9:00 am

NetworkNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Expands European Commercial Strategy Through Humanitas Collaboration

Regentis Biomaterials (NYSE American: RGNT) announced a collaboration with Humanitas Research Hospital in Milan, Italy, to support expanding clinical activities and commercial strategy for GelrinC(R) in Europe, where the product has CE Mark approval for knee cartilage repair. The collaboration includes Prof. Elizaveta Kon, an internationally recognized expert in cartilage regeneration and orthopedic innovation, who is expected to help lead development of Regentis’ European Centers of Excellence network, supporting surgeon education, clinical expertise and broader adoption of GelrinC(R) as the company advances commercialization. To view the full press release, visit https://nnw.fm/j7jt0 About Regentis Biomaterials Regentis Biomaterials Ltd is a regenerative…

Continue Reading

WednesdayApr 15, 2026 3:11 pm

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Targets Growth in Defense Sector with Strategic Appointment

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) recently announced the appointment of Matt McCrann as CEO of its U.S. subsidiary, a move that signals a focused push into the world’s largest defense market. “McCrann previously served as CEO of the U.S. subsidiary of DroneShield, where he led operational expansion during a period of revenue growth and increasing federal adoption,” an article discussing this reads. “McCrann’s mandate is operational rather than symbolic. He will lead SPARC AI’s North American expansion, build out U.S. infrastructure and teams, advance field evaluations and pilot…

Continue Reading

WednesdayApr 15, 2026 2:10 pm

NetworkNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Secures Up to C$30 Million Prepayment Facility and Offtake Agreement With Trafigura 

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.  LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced it has selected Trafigura Canada Limited to arrange and provide a prepayment financing facility of up to C$30 million along with a gold doré offtake agreement to support development of the Swanson Gold Deposit and operations at the Beacon Gold Mill in Québec, subject to definitive agreements and due diligence. The proposed facility, which includes no commodity hedging requirements and an initial tranche of up to C$15 million, is expected to fund ramp-up toward 1,250 tonnes per day processing capacity while providing a…

Continue Reading

WednesdayApr 15, 2026 1:18 pm

NetworkNewsBreaks – BluSky AI Inc. (BSAI) Expands Scalable Compute Access with Next-Gen Platform

BluSky AI (OTC: BSAI) is positioning at the forefront of a major shift in artificial intelligence infrastructure, where flexibility and predictable access to compute resources are becoming mission critical. “With AI workloads increasing at unprecedented rates, organizations are changing their outlook on traditional hyperscale cloud providers and finding alternatives that reduce vendor lock-in, provide the compute that is quickly becoming unavailable, while enhancing cost visibility and performance reliability. The company’s approach, anchored in the design of modular and quickly deployable data centers, offers a compelling solution for this evolving landscape,” a recent article reads. “BluSky AI is speeding up the rollout…

Continue Reading